Anticardiolipin Antibodies in Patients with Venous Thrombosis
作者:
S. Kapiotis,
W. Speiser,
I. Pabinger-Fasching,
P.A. Kyrle,
K. Lechner,
期刊:
Pathophysiology of Haemostasis and Thrombosis
(Karger Available online 1991)
卷期:
Volume 21,
issue 1
页码: 19-24
ISSN:1424-8832
年代: 1991
DOI:10.1159/000216197
出版商: S. Karger AG
关键词: Antiphospholipid antibodies;Anticardiolipin antibodies;Lupus anticoagulant;Thrombosis;venous
数据来源: Karger
摘要:
The levels of anticardiolipin antibodies (ACA) and lupus anticoagulant (LAC) were measured in 266 consecutive unselected patients with a history of venous thrombosis. 19 (7.1 %) had elevated levels of IgG- or IgM-ACA. The prevalence of LAC was 1 of 266 (0.4%) in the whole patient group and 1 of 19 (5.3%) in the ACA-positive group. Patients with elevated ACA levels did not differ from those with normal ACA with regard to age at the first thrombosis, risk of recurrence, presence of arterial thrombosis, and other clinical features. 8 out of 19 (42.1%) patients with elevated ACA levels also had elevated levels of antinuclear antibodies, but only 1 fulfilled the criteria of systemic lupus erythematosus. These data indicate that in some patients with elevated ACA, autoimmune processes may be present. The clinical significance of elevated ACA levels is uncertain.
点击下载:
PDF
(1838KB)
返 回